Supporters and opponents of Colorado’s statewide ballot measures have pumped $41.7 million just this year toward swaying public opinion on issues that could have far-reaching implications if passed in November.

During a presidential election year in which issues such as abortion access hang in the balance, and at a time when many families are struggling to make ends financially, Colorado’s ballot questions are taking on heightened importance. Measures such as a 22-week ban on abortions and having Colorado support the national popular vote for president are receiving attention — and contributions — from across the state and country. With less than a month to go, advocates are making their final pushes to Election Day — including in the money race.

The committee fighting the proposed ban on abortions after 22 weeks has brought in the most contributions of any issue committee at almost $6.5 million in 2019 and 2020, while proponents of Proposition 115 have raised a fraction of that, according to filings with the Colorado Secretary of State’s Office by Tuesday’s deadline. Three committees supporting the measure raised about $369,000.

Opposition to the abortion measure is being led by women’s reproductive rights groups and progressive allies such as ProgressNow Colorado, Colorado Organization for Latina Opportunity and Reproductive Rights, and Cobalt. Supporters of Proposition 115 include Catholic Charities and citizen advocates.

Although Colorado voters have rejected abortion bans three times before at the ballot box, the vote comes at a critical time with the U.S. Supreme Court vacancy left after the death of Justice Ruth Bader Ginsburg. President Donald Trump has nominated conservative Judge Amy Coney Barrett to replace her, leaving advocates worried about the potential of Roe v. Wade getting overturned.

Colorado is one of only seven states that doesn’t have gestational limits on when an abortion can take

Despite decent performance of the overall Finance sector in the third quarter, Citigroup C disappointed investors as reflected by its price performance. Shares of the company depreciated 15.6% in the July-September period compared with the industry’s 2.1% decline. The stock also lagged the S&P 500’s rally of 8.5% in the same time frame.

Like many other companies, performance of Citigroup has been affected by the pandemic. However, recent developments regarding faults in the company’s risk management systems, CFO’s comments on disappointing revenue performance in third-quarter 2020 and other legal issues pulled the stock even lower.

Price Performance

Factors in Detail

Citigroup witnessed a major setback when in mid-September The Wall Street Journal reported that the bank may have to face a public rebuke from The Office of the Comptroller of the Currency and the Federal Reserve. This was due to its failure to improve its risk management systems and procedures.

Notably, Citigroup was expected to face a consent order that would make it necessary for the company to take some immediate action and improve its faulty controlling systems.

Further, the stock met with investors’ pessimism when CFO Mark Mason said that he expects additional reserves to be created in the third quarter. Also, overall revenues are expected to decline in the high single-digit range on a year-over-year basis due to the impact of lower rates and reduced levels of business activities due to COVID-19.

The company’s legal encounters during the quarter were another key reason for the stock ending in red. In August, Citigroup had accidently transferred about $900 million to the creditors of renowned cosmetic company, Revlon. The lender was able to recover some of the amount and stated that it was a clerical error.

Further, at the end of September, Citigroup agreed to pay $4.5 million in fine